Squarepoint Ops »

Karyopharm Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2026-06-30 $623k 64k 9.77

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf (IWM)
Micron Technology (MU)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Applied Materials (AMAT)
Tesla Motors (TSLA)
Intel Corporation (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Squarepoint Ops

Top funds holding Karyopharm Therapeutics

RA Capital Management
Adage Capital Partners GP
Acorn Capital Advisors
Goldman Sachs Group
BlackRock
Vanguard Capital Management
Catalio Capital Management
Avidity Partners Management
Two Sigma Investments
Kalehua Capital Management
NEA Management Company
Susquehanna International
Geode Capital Management
Ghisallo Capital Management
Soleus Capital Management

View all funds holding Karyopharm Therapeutics